Jupiter Research Capital (Asia) Ltd’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
Other funds holding GPCR
BBA
Jupiter Research Capital (Asia) Ltd's GPCR Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd opened a new position in Structure Therapeutics (GPCR) in Q3 2026: 12,728 shares worth $398K. The stake represents 0.04% of the portfolio and ranks #402 among its holdings.
163 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd held 12,728 shares of Structure Therapeutics worth $398K as of Q3 2026.
- Structure Therapeutics was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
- Structure Therapeutics made up 0.04% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #402 holding.
- 163 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.